Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.
about
Novel drugs that target the metabolic reprogramming in renal cell cancerRenal cell carcinoma.The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate.Extraction and Quantification of Tryptophan and Kynurenine from Cultured Cells and Media Using a High Performance Liquid Chromatography (HPLC) System Equipped with an Ultra-Sensitive Diode Array Detector.Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer.Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinomaMass Defect-Based N,N-Dimethyl Leucine Labels for Quantitative Proteomics and Amine Metabolomics of Pancreatic Cancer Cells.Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis.In vivo Reprogramming of Cancer Metabolism by MYC.RNF20 Suppresses Tumorigenesis by Inhibiting SREBP1c-PTTG1 Axis in Kidney Cancer.Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches.Metabolomics for clinical use and research in chronic kidney disease.Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.An overview of renal metabolomics.Metabolomic profiling for early cancer detection: current status and future prospects.Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis.Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.Renal cell carcinoma: new insights and challenges for a clinician scientist.Metabolic reprogramming in clear cell renal cell carcinoma.Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.Applications of Metabolomics in Cancer Studies.Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI.Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells.Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell CarcinomaGlutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.Renal oncocytoma characterized by the defective complex I of the respiratory chain boosts the synthesis of the ROS scavenger glutathione.Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.Metabolomics and Metabolic Reprogramming in Kidney Cancer.Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors.Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells.
P2860
Q26740187-892819F4-425F-40A7-861D-AAF062135D11Q30235364-7CC4C707-F75A-4A14-B8C7-AE251C16C847Q30277177-C25845E1-7EA8-480E-B52E-0615D9F18B60Q34515993-A0499D30-A4C2-4C47-B3AE-90C02EF24EF0Q36003500-4798D75C-7BB4-46D7-8CD2-DF6CBF32B036Q36066391-AF169A00-DC3B-47D7-9AFB-2B605D1AED54Q36916207-AAF51113-1F6F-4F4A-AB40-5E10D484EA28Q37200709-076E99FA-0E4D-4B24-9EB7-8B6FAE084033Q37421650-41A36A44-129F-4D94-BCE5-7B0A39A701D4Q37584289-0026DD00-C6DA-4F9B-8215-9D7358120414Q37682589-77A20D6A-71FC-446E-9FED-3D5CDBA39BD5Q37687020-46418BA0-6AC4-44DA-ABB6-3B767B2EA54AQ37697020-ACB6862C-8AB5-481D-883A-8860627BE347Q37746816-2CD50C64-3ECD-44A5-B555-56835B468F0EQ38639202-D2B1F634-2CF9-4C9C-A359-3EBF6798631BQ38704618-4E452ABB-548F-4B21-B16D-8A4FCF1568C6Q38750287-2F8750B3-6CF4-4773-A95C-D8AA55D0F720Q38759201-2776CB6B-204B-4DE4-B704-536A926926B6Q38763176-3772DD3E-64FE-419F-BFA2-DDB1522BCFF1Q38815775-D3685D6B-35C2-43FB-9184-4AC2C1699100Q38819884-B1082992-5CDE-46AA-B80D-CAD8CF060132Q38822454-2DCCF891-0727-4A86-B2BA-BEBE986009DBQ38830422-E2960420-6BC6-4CF3-9EC6-64A3B6E7E125Q38976447-07A681F9-5E35-443C-B37F-701E1E4710C3Q39222755-9CABA676-0952-44A0-BC80-596F94F703BEQ39290307-8398838E-0CB4-4D64-98BA-AC60D0B559A9Q40160539-78309074-14B4-4220-95AC-7DBA07E3FE7AQ40354565-A99243CE-CAC0-4F2C-B34C-B6A80F9756D4Q41252294-085A3E65-D909-4529-95BE-2CF31ECF3570Q41328196-DEB5E8EB-1824-44AD-8F6F-748366C3656DQ42293369-BFE72E84-7261-416C-A2E4-455997B01FD2Q46105764-39CC382D-FC13-4B71-9D7E-5B73B300C886Q47131093-44EA3918-A223-4AE0-8B26-466C99021066Q47173796-41800173-215E-4C7E-BA3B-E90AB11A10A7Q49678727-2C710CD2-8814-4C8B-A9F8-1A9187626430Q52585312-95086E86-0BD4-4B7E-9019-310DB5D32A8DQ52618376-B491E8D9-3E91-4C99-956C-09A25256ACCDQ54667772-64E3B824-9787-422A-82CA-54D6251C1524Q54964002-47737F16-4446-4496-91C9-12EE73BD735AQ55078174-AC9CBE1E-C5DE-407F-8EDE-698C8FA3BADF
P2860
Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Grade-Dependent Metabolic Repr ...... ics and Metabolomics Analysis.
@ast
Grade-Dependent Metabolic Repr ...... ics and Metabolomics Analysis.
@en
type
label
Grade-Dependent Metabolic Repr ...... ics and Metabolomics Analysis.
@ast
Grade-Dependent Metabolic Repr ...... ics and Metabolomics Analysis.
@en
prefLabel
Grade-Dependent Metabolic Repr ...... ics and Metabolomics Analysis.
@ast
Grade-Dependent Metabolic Repr ...... ics and Metabolomics Analysis.
@en
P2093
P2860
P1433
P1476
Grade-Dependent Metabolic Repr ...... ics and Metabolomics Analysis.
@en
P2093
A Ari Hakimi
Benjamin Stewart
Bruce Neri
Cristina Bianchi
Dallas R Donohoe
Dexter Morin
Hiromi I Wettersten
James J Hsieh
Josephine F Trott
Omran Abu Aboud
P2860
P304
P356
10.1158/0008-5472.CAN-14-1703
P407
P577
2015-05-07T00:00:00Z